China Walvax's mRNA COVID vaccine obtains first approval overseas




  • In Health
  • 2022-09-29 15:02:19Z
  • By Reuters
 

JAKARTA/BEIJING (Reuters) -The Indonesian food and drugs agency (BPOM) said on Thursday it has approved the emergency use of an mRNA COVID-19 vaccine developed by China's Walvax Biotechnology.

It is the first authorisation for a China-developed COVID shot based on the novel mRNA technology, which Pfizer/BioNTech and Moderna also use in their COVID vaccines, after more than two years of development.

The AWcorna shot, which is designed based on the original strain of the coronavirus, has yet to generate efficacy readings from large trials to show how well it can reduce the risk of COVID cases and deaths from the disease.

China has not yet authorised local use of the shot, previously known as ARCoV.

Walvax co-developed the vaccine with Suzhou Abogen Biosciences and a Chinese military-backed institution.

The two firms are also separately working on their own coronavirus variant-targeting candidates based on the mRNA technology.

(Reporting by Stanley Widianto in Jakarta and Roxanne Liu in Beijing; Editing by Kirsten Donovan)

COMMENTS

More Related News

China Covid: Xi
China Covid: Xi's face-saving exit from his signature policy

If you want to know what the government's plan is, look at what it does rather than what it says.

China
China's COVID-19 policy in flux
  • US
  • 2022-12-05 10:16:40Z

China is set to announce new measures to further ease some of the world's toughest COVID-19 curbs as early as Wednesday, sources told Reuters, with investors...

Tesla sold 100,291 China-made vehicles in Nov -Xinhua
Tesla sold 100,291 China-made vehicles in Nov -Xinhua

Tesla Inc delivered 100,291 China-made electric vehicles (EVs) in November, the highest monthly sales since its Shanghai factory opened in late 2020, a...

Gold Steady Ahead of US Data as Traders Eye China Reopening
Gold Steady Ahead of US Data as Traders Eye China Reopening

(Bloomberg) -- Gold steadied after earlier touching the highest level since July as traders weighed more US economic data and China's relaxation of its...

Investors bet China
Investors bet China's rally on easing COVID curbs will be furious but fleeting

Investors piling into China's tourism, catering and beverage stocks as Beijing eases strict COVID-19 curbs are also keeping an eye on the exits, factoring in...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health